Detalhe da pesquisa
1.
Image-based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno-oncology Biomarker Working Group on Breast Cancer.
J Pathol
; 262(3): 271-288, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38230434
2.
Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.
J Pathol
; 260(5): 514-532, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37608771
3.
Impact of the menstrual cycle on commercial prognostic gene signatures in oestrogen receptor-positive primary breast cancer.
Breast Cancer Res Treat
; 190(2): 295-305, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34524591
4.
Impact of aromatase inhibitor treatment on global gene expression and its association with antiproliferative response in ER+ breast cancer in postmenopausal patients.
Breast Cancer Res
; 22(1): 2, 2019 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31892336
5.
Dissecting the predictive value of MAPK/AKT/estrogen-receptor phosphorylation axis in primary breast cancer to treatment response for tamoxifen over exemestane: a Translational Report of the Intergroup Exemestane Study (IES)-PathIES.
Breast Cancer Res Treat
; 175(1): 149-163, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30680659
6.
Novel 18-gene signature for predicting relapse in ER-positive, HER2-negative breast cancer.
Breast Cancer Res
; 20(1): 103, 2018 09 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30180877
7.
Intrinsic subtypes and benefit from postmastectomy radiotherapy in node-positive premenopausal breast cancer patients who received adjuvant chemotherapy - results from two independent randomized trials.
Acta Oncol
; 57(1): 38-43, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29172851
8.
Heterogeneity in global gene expression profiles between biopsy specimens taken peri-surgically from primary ER-positive breast carcinomas.
Breast Cancer Res
; 18(1): 39, 2016 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27036195
9.
Molecular profiling of aromatase inhibitor sensitive and resistant ER+HER2- postmenopausal breast cancers.
Nat Commun
; 14(1): 4017, 2023 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37419892
10.
Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727).
Clin Cancer Res
; 29(18): 3691-3705, 2023 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37574209
11.
Efficacy and Safety of TRC105 Plus Pazopanib vs Pazopanib Alone for Treatment of Patients With Advanced Angiosarcoma: A Randomized Clinical Trial.
JAMA Oncol
; 8(5): 740-747, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35357396
12.
Development and validation for research assessment of Oncotype DX® Breast Recurrence Score, EndoPredict® and Prosigna®.
NPJ Breast Cancer
; 7(1): 15, 2021 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33579961
13.
Best Practices for Spatial Profiling for Breast Cancer Research with the GeoMx® Digital Spatial Profiler.
Cancers (Basel)
; 13(17)2021 Sep 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34503266
14.
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer.
NPJ Breast Cancer
; 6: 17, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32411819
15.
Identifying Biomarkers to Pair with Targeting Treatments within Triple Negative Breast Cancer for Improved Patient Stratification.
Cancers (Basel)
; 11(12)2019 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31769425
16.
Heterocellular gene signatures reveal luminal-A breast cancer heterogeneity and differential therapeutic responses.
NPJ Breast Cancer
; 5: 21, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31396557
17.
Genomic Instability and TP53 Genomic Alterations Associate With Poor Antiproliferative Response and Intrinsic Resistance to Aromatase Inhibitor Treatment.
JCO Precis Oncol
; 32019.
Artigo
em Inglês
| MEDLINE | ID: mdl-32914010
18.
Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor-Positive Early Breast Cancer: PALLET Trial.
J Clin Oncol
; 37(3): 178-189, 2019 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30523750
19.
Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial.
Nat Med
; 24(5): 628-637, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29713086
20.
Intrinsic Subtype and Therapeutic Response Among HER2-Positive Breaty st Tumors from the NCCTG (Alliance) N9831 Trial.
J Natl Cancer Inst
; 109(2)2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27794124